Up | AC
Home Page
Food and
Drug Administration
Psychopharmacologic Drugs Advisory Committee
December 13, 2006
Disclaimer
Portions of this document have been determined to be exempt
from disclosure under the Freedom of Information Act (the
FOIA) (5 U.S.C. §552). These redacted portions will appear
as white space on the screen or on the printed page.
FDA Briefing
Document